Cargando…
Sox12 Is a Cancer Stem-Like Cell Marker in Hepatocellular Carcinoma
Recent studies on molecular carcinogenesis suggest that the chemo-resistance of some cancers is largely due to presence of cancer stem cells (CSCs), which affect the chemotherapy outcome for hepatocellular carcinoma (HCC). However, currently no consensus on a CSC phenotype in HCC has been obtained....
Autores principales: | Zou, Song, Wang, Chen, Liu, Jiansheng, Wang, Qun, Zhang, Dongdong, Zhu, Shengnan, Xu, Shengyuan, Kang, Mafei, He, Shaozhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Molecular and Cellular Biology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712514/ https://www.ncbi.nlm.nih.gov/pubmed/29127951 http://dx.doi.org/10.14348/molcells.2017.0129 |
Ejemplares similares
-
Effectiveness and safety of anlotinib with or without S-1 in the treatment of patients with advanced hepatocellular carcinoma in a Chinese population: a prospective, phase 2 study
por: Kang, Mafei, et al.
Publicado: (2023) -
MicroRNA-211 promotes non-small-cell lung cancer proliferation and invasion by targeting MxA
por: Kang, Mafei, et al.
Publicado: (2017) -
SOX9 is a novel cancer stem cell marker surrogated by osteopontin in human hepatocellular carcinoma
por: Kawai, Takayuki, et al.
Publicado: (2016) -
SOX2 Is a Marker for Stem-like Tumor Cells in Bladder Cancer
por: Zhu, Fengyu, et al.
Publicado: (2017) -
MicroRNA-744 inhibits migration and invasion of hepatocellular carcinoma cells by targeting SOX12
por: Zhang, Wei, et al.
Publicado: (2022)